Binding Database

BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 752K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

14 articles for D Jung

The following articles (labelled with PubMed ID or TBD) are for your review

PMID

Data

Article Title

Organization

Discovery and Characterization of GSK2801, a Selective Chemical Probe for the Bromodomains BAZ2A and BAZ2B.

Glaxosmithkline

Design and synthesis of a piperazinylalkylisoxazole library for subtype selective dopamine receptor ligands.

Institute of Science and Technology

Novel Rho kinase inhibitors with anti-inflammatory and vasodilatory activities.

Glaxosmithkline

2-Phenyl-8-(1-phenylallyl)-chromenone compounds have a pan-PPAR modulator pharmacophore.

Seoul National University

Click chemistry for improvement in selectivity of quinazoline-based kinase inhibitors for mutant epidermal growth factor receptors.

Chung-Ang University

Bicyclic ketone compounds and methods of use thereof

Genentech

Lysophosphatidic acid receptor 1 (LPAR1) inhibitor compounds

Eli Lilly

Pyrazolo[1,5-a]pyrazin-4-yl derivatives

Pfizer

Pyrrolotriazine compounds as tam inhibitors

Incyte

Multiple kinase pathway inhibitors

Tolero Pharmaceuticals

Substituted pyrido[4,3-d]pyrimidines as Wee-1 inhibitors

Almac Discovery

Creating an a7 Nicotinic Acetylcholine Recognition Domain from the Acetylcholine-binding Protein

Uc San Diego

Optimization of a pyrazolo[1,5-a]pyrimidine class of KDR kinase inhibitors: improvements in physical properties enhance cellular activity and pharmacokinetics.

Merck Research Laboratories

Synthesis of alkenyldiarylmethane (ADAM) non-nucleoside HIV-1 reverse transcriptase inhibitors with non-identical aromatic rings.

Purdue University